Skip to content

Annexon, Inc.

ANNX· NasdaqCore metricsCIK 1528115

Pharmaceutical preparations553 peers

Last sale
Nov 6, 2026 · +4.75%
Market cap
$625.83M
149.36M shares
Filings
524
—
—
—
-$51.22M
Q3 2026N/M FY25 yoy
-$52.24M
Q3 2026N/M FY25 yoy
-$143.62M
Q3 2026derivedN/M FY25 yoy
-$0.25
Q3 2026N/M FY25 yoy
$102.39M
Q3 2026+227.4% FY25 yoy
$625.83M
—
—
4.4×
-29.80%
—

FY2025 figures · derived

Price

$4.19+39.20%+$1.18past year
Nov 6, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Research And Development

$184.70MFY 2025
$184.70M0FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$184,698,000reported
FY 20242024-12-31$119,448,000reported
FY 20232023-12-31$113,756,000reported
FY 20222022-12-31$112,501,000reported
FY 20212021-12-31$100,066,000reported
FY 20202020-12-31$49,271,000reported
FY 20192019-12-31$24,524,000reported

Pharmaceutical preparations

Annexon, Inc. is the 174th largest of the 554 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Annexon, Inc. · CIK 1528115 · Engraved from SEC EDGAR